Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | OLYMY |
---|---|---|
09:32 ET | 162 | 15.42 |
09:39 ET | 400 | 16 |
09:48 ET | 475 | 16.0185 |
09:57 ET | 218 | 16.0612 |
10:04 ET | 2200 | 16 |
10:08 ET | 490 | 16 |
10:20 ET | 142 | 16.028 |
10:22 ET | 981 | 16.035 |
10:26 ET | 3000 | 16.06 |
10:31 ET | 1631 | 16 |
10:45 ET | 113 | 16.022 |
11:16 ET | 700 | 16.04 |
11:21 ET | 138 | 16.02 |
11:34 ET | 815 | 16.06 |
11:48 ET | 113 | 16.015 |
12:06 ET | 820 | 16.022 |
12:08 ET | 1200 | 15.992 |
12:17 ET | 2737 | 16.01 |
12:26 ET | 399 | 16.01 |
12:28 ET | 556 | 16.028 |
12:30 ET | 1668 | 15.98 |
12:35 ET | 3664 | 16.02 |
12:44 ET | 213 | 16.02 |
12:51 ET | 100 | 16.0136 |
01:02 ET | 349 | 16.025 |
01:11 ET | 108 | 16.025 |
01:22 ET | 700 | 16.06 |
01:36 ET | 121 | 16.0025 |
01:44 ET | 1235 | 16.036 |
01:49 ET | 1275 | 16.0504 |
01:56 ET | 332 | 16.02 |
02:39 ET | 198 | 16.01 |
02:41 ET | 523 | 16.01 |
02:45 ET | 118 | 16.01 |
02:48 ET | 284 | 16.01 |
03:06 ET | 905 | 16.025 |
03:10 ET | 187 | 16.01 |
03:12 ET | 288 | 16.01 |
03:14 ET | 190 | 16.01 |
03:19 ET | 130 | 16.007 |
03:26 ET | 500 | 16.03 |
03:35 ET | 1447 | 16.04 |
03:42 ET | 500 | 16.03 |
03:44 ET | 2641 | 16.03 |
03:46 ET | 133 | 16.01 |
03:51 ET | 3608 | 16.015 |
03:53 ET | 1972 | 16.002 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Olympus Corp | 18.8B | 33.0x | --- |
LENSAR Inc | 86.5M | -5.1x | --- |
Cytosorbents Corp | 48.7M | -2.5x | --- |
908 Devices Inc. | 95.0M | -1.5x | --- |
Sensus Healthcare Inc | 146.4M | 15.6x | --- |
Bionano Genomics Inc | 17.7M | -0.1x | --- |
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $18.8B |
---|---|
Revenue (TTM) | $6.3B |
Shares Outstanding | 1.2B |
Dividend Yield | 1.44% |
Annual Dividend Rate | 0.2302 USD |
Ex-Dividend Date | 03-26-24 |
Pay Date | 06-20-24 |
Beta | 0.79 |
EPS | $0.49 |
Book Value | $4.20 |
P/E Ratio | 33.0x |
Price/Sales (TTM) | 3.0 |
Price/Cash Flow (TTM) | 18.9x |
Operating Margin | 11.23% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.